Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective

J Han, M Won, JH Kim, E Jung, K Min… - Chemical Society …, 2020 - pubs.rsc.org
Cancer stem cells (CSCs), also called tumor-initiating cells (TICs), have been studied
intensively due to their rapid proliferation, migration, and role in the recurrence of cancer. In …

Advancement of the emerging field of RNA nanotechnology

D Jasinski, F Haque, DW Binzel, P Guo - ACS nano, 2017 - ACS Publications
The field of RNA nanotechnology has advanced rapidly during the past decade. A variety of
programmable RNA nanoparticles with defined shape, size, and stoichiometry have been …

Cancer stem cell in breast cancer therapeutic resistance

X Bai, J Ni, J Beretov, P Graham, Y Li - Cancer treatment reviews, 2018 - Elsevier
Abstract Development of therapeutic resistance and metastasis is a major challenge with
current breast cancer (BC) therapy. Mounting evidence suggests that a subpopulation of …

Oligonucleotide aptamers: new tools for targeted cancer therapy

H Sun, X Zhu, PY Lu, RR Rosato, W Tan… - Molecular Therapy-Nucleic …, 2014 - cell.com
Aptamers are a class of small nucleic acid ligands that are composed of RNA or single-
stranded DNA oligonucleotides and have high specificity and affinity for their targets. Similar …

Exosomes and nanoengineering: a match made for precision therapeutics

PHL Tran, D Xiang, TTD Tran, W Yin… - Advanced …, 2020 - Wiley Online Library
Targeted exosomal delivery systems for precision nanomedicine attract wide interest across
areas of molecular cell biology, pharmaceutical sciences, and nanoengineering. Exosomes …

Treating metastatic cancer with nanotechnology

A Schroeder, DA Heller, MM Winslow… - Nature Reviews …, 2012 - nature.com
Metastasis accounts for the vast majority of cancer deaths. The unique challenges for
treating metastases include their small size, high multiplicity and dispersion to diverse organ …

Aptamer in bioanalytical applications

AB Iliuk, L Hu, WA Tao - Analytical chemistry, 2011 - ACS Publications
(2009À2010), thefield of aptamer research has continuously generated lots of interest in the
scientific community. Aptamers, first reported by three groups independently in 1990, 1À3 …

Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture

Y Song, Z Zhu, Y An, W Zhang, H Zhang, D Liu… - Analytical …, 2013 - ACS Publications
Epithelial cell adhesion molecule (EpCAM) is overexpressed in most solid cancers and is an
ideal antigen for clinical applications in cancer diagnosis, prognosis, imaging, and therapy …

Aptamers in biomedicine: Selection strategies and recent advances

G Ștefan, O Hosu, K De Wael, MJ Lobo-Castañón… - Electrochimica …, 2021 - Elsevier
Aptamers have come in the spotlight as bio-mimetic molecular recognition elements in the
field of biomedicine due to various applications in diagnostics, drug delivery, therapeutics …

[HTML][HTML] Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer

A Sheikh, S Md, P Kesharwani - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Breast carcinomas repeat their number and grow exponentially making it extremely frequent
malignancy among women. Approximately, 70–80% of early diagnosed or non-metastatic …